Healthcare - Medical - Instruments & Supplies - NASDAQ - US
$ 2.41
-23 %
$ 119 M
Market Cap
-2.06
P/E
INCOME STATEMENT
96.6 M
REVENUE
-57.7 M
OPERATING INCOME
-63.3 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Akoya Biosciences, Inc.
| Revenue | 96.6 M |
| Cost Of Revenue | 40.3 M |
| Gross Profit | 56.3 M |
| Operating Expenses | 104 M |
| Operating Income | -57.7 M |
| Other Expenses | 5.66 M |
| Net Income | -63.3 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 96.6 | 74.9 | 54.9 | 42.4 | 42.2 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 40.3 | 31.5 | 20.7 | 16.5 | 17.6 |
| Gross Profit | 56.3 | 43.4 | 34.2 | 25.9 | 24.7 |
| OPERATING INCOME | |||||
| Operating Expenses | 104.3 | 109.6 | 71.4 | 37.4 | 38.2 |
| Selling, General and Administrative Expenses | 82.4 | 79.7 | 51.0 | 24.0 | 26.4 |
| Research and Development Expenses | 21.9 | 23.2 | 15.7 | 9.6 | 8.8 |
| Operating Income | (57.7) | (66.2) | (37.2) | (11.5) | (13.5) |
| PRE-TAX INCOME | |||||
| Interest Income Expense | 8.8 | 4.6 | 3.1 | 2.7 | 1.9 |
| Total Other Income | (5.6) | (4.4) | (3.8) | (4.7) | (2.3) |
| Pre-Tax Income | (63.3) | (70.5) | (43.1) | (16.7) | (14.6) |
| NET INCOME | |||||
| Tax Provision | 40 K | 0.1 | (0.1) | 42 K | 0.2 |
| Net Income | (63.3) | (70.6) | (42.9) | (16.7) | (14.8) |
| EPS | 1.43 | 1.87 | 1.15 | 0.45 | 0.4 |